DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Davies AM, Ruel C, Lara PN. et al.
The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
J Thorac Oncol 2008;
3 (01) 68-74
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.